Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

被引：0

作者：

Hubert G Nüßlein

Rieke Alten

Mauro Galeazzi

Hanns-Martin Lorenz

Dimitrios Boumpas

Michael T Nurmohamed

William G Bensen

Gerd R Burmester

Hans-Hartmut Peter

Franz Rainer

Karel Pavelka

Melanie Chartier

Coralie Poncet

Christiane Rauch

Manuela Le Bars

机构：

[1] University of Erlangen-Nuremberg,Schlosspark

[2] University Medicine,Klinik

[3] University of Siena,Institute of Rheumatology and Clinic of Rheumatology

[4] University Hospital Heidelberg,undefined

[5] University of Crete,undefined

[6] VU University Medical Center/Jan van Breemen Research Institute,undefined

[7] St. Joseph’s Hospital/McMaster University,undefined

[8] Charité-Universitätsmedizin Berlin,undefined

[9] University Medical Center Freiburg,undefined

[10] Hospital Barmherzige Brueder,undefined

[11] Charles University,undefined

[12] Chiltern International,undefined

[13] Docs International,undefined

[14] Bristol-Myers Squibb,undefined

[15] Bristol-Myers Squibb,undefined

来源：

BMC Musculoskeletal Disorders | / 15卷

关键词：

Rheumatoid arthritis; Biological agents; Abatacept; Effectiveness; Safety; Registries;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
Nuesslein, Hubert G.
Alten, Rieke
Galeazzi, Mauro
Lorenz, Hanns-Martin
Boumpas, Dimitrios
Nurmohamed, Michael T.
Bensen, William G.
Burmester, Gerd R.
Peter, Hans-Hartmut
Rainer, Franz
Pavelka, Karel
Chartier, Melanie
Poncet, Coralie
Rauch, Christiane
Le Bars, Manuela
[J]. BMC MUSCULOSKELETAL DISORDERS, 2014, 15
[2] Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis in a Real-life Setting in European and Canadian Populations: A 6-Month Interim Analysis of the ACTION Study
Khraishi, Majed
Nuesslein, Hubert
Lorenz, Hannes
Alten, Rieke
Bensen, William
Bessette, Louis
Burmester, Gerd
Peter, Hans-Hartmut
Chartier, Melanie
Poncet, Coralie
Rauch, Christiane
Le Bars, Manuela
[J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1728 - 1728
[3] Real-world Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the ACTION Study
Bensen, William
Nuesslein, Hubert
Alten, Rieke
Galeazzi, Mauro
Lorenz, Hanns-Martin
Boumpas, Dimitrios
Nurmohamed, Michael
Burmester, Gerd
Peter, Hans-Hartmut
Rainer, Franz
Pavelka, Karel
Charner, Melanie
Poncet, Coralie
Rauch, Christiane
Le Bars, Manuela
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 985 - 985
[4] REAL-WORLD EFFICACY AND SAFETY OF ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS: 12-MONTH INTERIM ANALYSIS OF THE ACTION STUDY
Nusslein, Hubert
Alten, Rieke
Galeazzi, Mauro
Lorenz, Hannes M.
Boumpas, Dimitrios
Nurmohamed, Michael T.
Bensen, William
Burmester, Gerd R.
Peter, Hans-Hartmut
Rainer, Franz
Pavelka, Karel
Chartier, Melanie
Poncet, Coralie
Rauch, Christiane
Le Bars, Manuela
[J]. RHEUMATOLOGY, 2013, 52 : 90 - 91
[5] Real-World Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the Action Study.
Nuesslein, H.
Alten, R.
Galeazzi, M.
Lorenz, H. M.
Boumpas, Dimitrios
Nurmohamed, M. T.
Bensen, W.
Burmester, G. R.
Peter, H. -H.
Rainer, F.
Pavelka, Karel
Chartier, M.
Poncet, C.
Rauch, C.
Le Bars, M.
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S199 - S200
[6] Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
Rieke Alten
Xavier Mariette
René-Marc Flipo
Roberto Caporali
Maya H. Buch
Yusuf Patel
Sara Marsal
Raimon Sanmartí
Michael T. Nurmohamed
Hedley Griffiths
Peter Peichl
Bettina Bannert
Melanie Chartier
Sean E. Connolly
Karissa Lozenski
Christiane Rauch
[J]. Clinical Rheumatology, 2022, 41 : 2361 - 2373
[7] Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
Alten, Rieke
Mariette, Xavier
Flipo, Rene-Marc
Caporali, Roberto
Buch, Maya H.
Patel, Yusuf
Marsal, Sara
Sanmarti, Raimon
Nurmohamed, Michael T.
Griffiths, Hedley
Peichl, Peter
Bannert, Bettina
Chartier, Melanie
Connolly, Sean E.
Lozenski, Karissa
Rauch, Christiane
[J]. CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2361 - 2373
[8] Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study
Bessette, Louis
Chan, Jonathan
Chow, Andrew
Lisnevskaia, Larissa
Richard, Nicolas
Fournier, Pierre-Andre
Liazoghli, Dalinda
Girard, Tanya
Haaland, Derek
[J]. RHEUMATOLOGY AND THERAPY, 2024, 11 (03) : 633 - 648
[9] The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study
Mariette, Xavier
Alten, Rieke
Nuesslein, Hubert G.
Galeazzi, Mauro
Lorenz, Hanns-Martin
Cantagrel, Alain
Chartier, Melanie
Poncet, Coralie
Rauch, Christiane
Le Bars, Manuela
[J]. JOINT BONE SPINE, 2017, 84 (05) : 571 - 576
[10] ASCORE, A 2-YEAR, OBSERVATIONAL, PROSPECTIVE MULTICENTRE STUDY OF SUBCUTANEOUS ABATACEPT FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN ROUTINE CLINICAL PRACTICE: 1-YEAR INTERIM ANALYSIS
Alten, Rieke
Mariette, Xavier
Buch, Maya
Caporali, Roberto
Flipo, Rene-Marc
Forster, Adrian
Nurmohamed, Michael
Patel, Yusuf
Peichl, Peter
Sanmarti, Raimon
Chartier, Melanie
Heitzmann, Julia
Rauch, Christiane
Connolly, Sean
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1639 - 1639

← 1 2 3 4 5 →